新型抗体竞争结合试验识别了与保护相关的独特血清学特征
Jessica S Bolton1, Randall S MacGill2, Emily Locke2
1Biologics Research & Development, Walter Reed Army Institute of Research (WRAIR), Silver Spring, MD, United States.
Frontiers in immunology
|December 28, 2023
概括
一种新的测定方法测量了针对疟疾环体蛋白 (CSP) 的抗体,区分了受保护和未受保护的个体. 该工具有助于选择有效的CSP疫苗,并改进疟疾预防策略.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 传染性疾病 传染性疾病
背景情况:
- 血红细胞前疟疾疫苗旨在提供对等离子杆菌感染的无菌保护,减少相关的发病率和死亡率.
- P. falciparum的环球体蛋白 (CSP) 是疟疾疫苗的主要点,最近取得了成功.
- 提高CSP疫苗的疗效需要更好的临床前候选人选择,需要对免疫相关的更深入的理解.
研究的目的:
- 开发一种新的测定方法,以评估针对CSP的疫苗诱导抗体的质量和表位特异度.
- 建立一种基于对CSP的抗体反应来区分受保护和未受保护个体的方法.
主要方法:
- 开发使用具有良好特征的单克隆抗体 (mAbs) 向关键CSP表位的多重竞争试验.
- 评估疫苗诱导的抗体,通过测量它们的等价性与一个小组的CSP-表位特异的mAbs.
- 该试验应用于控制的人类疟疾感染 (CHMI) 试验中的血清,该试验涉及RTS,S疫苗.
主要成果:
- 该试验提供了RTS,S-免疫血清中抗体反应的定量表位特异性概况.
- 这种特征成功地区分了受疟疾保护的个体和未受保护的个体.
- 疫苗疗效与表位微细特异性之间的相关性凸显了特定抗体标的重要性.
结论:
- 开发的血清学等价性试验可以为未来的CSP疫苗设计和辅助剂选择提供信息.
- 这种方法为在不同抗原和模型中比较和下调选择疫苗配方提供了有价值的工具.
- 这项测试有助于我们更好地了解疟疾疫苗的保护相关性.
更多相关视频
05:25Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research
Published on: July 14, 2023
1.5K
07:08A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System
Published on: April 6, 2021
5.1K
相关概念视频
01:26Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
01:25Antibody Structure and Classes
915
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
915